Literature DB >> 28450721

CAR T therapies drive into new terrain.

Katie Kingwell.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28450721     DOI： 10.1038/nrd.2017.84

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  8 in total

Review 1.  The Single-Cell Level Perspective of the Tumor Microenvironment and Its Remodeling by CAR-T Cells.

Authors:  Sanxing Gao; Ryohichi Sugimura
Journal:  Cancer Treat Res       Date:  2022

2.  Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma.

Authors:  Bryan D Choi; Donald M O'Rourke; Marcela V Maus
Journal:  J Target Ther Cancer       Date:  2017-08

Review 3.  Current progress in innovative engineered antibodies.

Authors:  William R Strohl
Journal:  Protein Cell       Date:  2017-08-18       Impact factor: 14.870

4.  Computational Model of Chimeric Antigen Receptors Explains Site-Specific Phosphorylation Kinetics.

Authors:  Jennifer A Rohrs; Dongqing Zheng; Nicholas A Graham; Pin Wang; Stacey D Finley
Journal:  Biophys J       Date:  2018-08-22       Impact factor: 4.033

Review 5.  Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.

Authors:  Qianquan Ma; Wenyong Long; Changsheng Xing; Junjun Chu; Mei Luo; Helen Y Wang; Qing Liu; Rong-Fu Wang
Journal:  Front Immunol       Date:  2018-12-21       Impact factor: 7.561

6.  Development of N-Acetylated Dipalmitoyl-S-Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 Agonists.

Authors:  Yang Zhou; Abid H Banday; Victor J Hruby; Minying Cai
Journal:  Molecules       Date:  2019-09-27       Impact factor: 4.411

Review 7.  Turning enemies into allies-reprogramming tumor-associated macrophages for cancer therapy.

Authors:  Martina Molgora; Marco Colonna
Journal:  Med (N Y)       Date:  2021-06-15

8.  Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study.

Authors:  Yajing He; Yabing Guo; Jinzhang Chen; Xiaoyun Hu; Xiaoshuang Li; Yanjun Kong; Xiaoyong Zhang; Xiangjun Zhou; Li Liu; Jinlin Hou
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.